Canada Endoscopy Devices Market: Market Size & Forecast 2026

Canada's endoscopy devices market represents a meaningful slice of the country's broader medical device industry, which itself produces more than CAD 24 billion in sector output. Within this landscape, endoscopy devices form a well-established segment that supplies hospitals, ambulatory surgical centers, and specialty clinics with flexible and rigid scopes, visualization systems, and operative accessories. Demand is anchored in the universal public health system, where procedural volumes for screening colonoscopy, diagnostic gastroscopy, and minimally invasive surgery continue to rise.

• •Market size valued at approximately USD 1.36 billion in 2025.
• •Forecast CAGR of 5.66% through 2029-2033, taking the market toward USD 1.8 billion.
• •Sits within Canada's overall medical device sector, which generates over CAD 24 billion in annual output.

An aging Canadian population is increasing the prevalence of conditions such as colorectal cancer, inflammatory bowel disease, and benign prostatic hyperplasia, all of which depend on endoscopic diagnosis or treatment. Provincial health authorities have launched wait-time reduction strategies that prioritize diagnostic and therapeutic endoscopy, expanding procedure throughput. At the same time, hospitals are upgrading aging scope inventories and adopting higher-resolution imaging, therapeutic accessories, and single-use devices that raise per-procedure equipment value.

• •Demographic aging and rising chronic disease burden are lifting procedure volumes.
• •Provincial wait-time reduction initiatives are accelerating investment in endoscopy capacity.
• •Replacement demand for HD and 4K visualization systems is increasing average equipment value per procedure.

The market is commonly segmented by product type into endoscopy operative devices, visualization systems, and accessories, with gastrointestinal endoscopy representing the largest application area. Canada's gastrointestinal endoscopic devices submarket is forecast to grow from roughly USD 269 million in 2024 to USD 388 million by 2030, while operative devices are projected to rise from USD 222 million in 2023 toward USD 379 million by 2030. Activity is concentrated in major provinces with large tertiary hospitals, notably Ontario, Quebec, Alberta, and British Columbia, where academic centers perform the highest volumes of advanced endoscopic procedures.

• •GI endoscopy is the largest application segment, growing at roughly 6.3% CAGR.
• •Endoscopy operative devices represent the fastest-growing submarket at approximately 8% CAGR.
• •Procedural demand is centered in Ontario, Quebec, Alberta, and British Columbia.

What are the recent trends and outlook?

Key trends shaping the next phase of the market include wider adoption of single-use endoscopes to mitigate cross-contamination risk, AI-enabled lesion detection during colonoscopy, and integration of endoscopy suites with hospital imaging and data systems. Minimally invasive techniques continue to replace open surgical approaches, lifting demand for advanced operative endoscopy. With sustained demographic and policy tailwinds, the market is positioned to remain on a steady mid-single-digit growth trajectory through the early 2030s.

• •Single-use and disposable endoscopes are gaining traction in infection-sensitive settings.
• •AI-assisted detection and procedural guidance tools are entering routine clinical use.
• •Minimally invasive surgery adoption continues to expand the addressable patient population.